Hishida O, Ayisi N K, Aidoo M, Brandful J, Ampofo W, Osei-Kwasi M, Ido E, Igarashi T, Takehisa J, Miura T
Research Center for Immunodeficiency Virus, Kyoto University, Japan.
AIDS. 1994 Sep;8(9):1257-61. doi: 10.1097/00002030-199409000-00006.
To determine seroprevalence among suspected AIDS patients in Ghana in relation to clinical manifestations.
Blood samples and medical records were collected from 290 Ghanaian patients with suspected AIDS in 1990 and 1992. Seroprevalence of HIV-1, HIV-2 and human T-cell leukemia virus (HTLV-1) were investigated by the particle agglutination method, indirect immunofluorescence assay, the monoepitope enzyme-linked immunosorbent assay and Western blot.
The specimens were classified into five serologic categories: 78 were HIV-1-positive (26.9%), 25 were HIV-2-positive (8.6%), 17 dual-positive (5.9%), 16 indeterminate (5.5%) and 154 seronegative (53.1%). No significant difference was found between the clinical symptoms of patients with HIV-1 and HIV-2 infection. Of the patients, 14 (4.8%) were HTLV-1-seropositive, of whom 11 were also HIV-positive, indicating a significant correlation between the two groups of viral infections (P < 0.01). However, there was no evidence of an increase in severity of symptoms in cases of dual infection with HTLV-1 and HIV.
HIV-1 infection is now dominant in Ghana in contrast to our previous survey in 1986 which showed the dominance of HIV-2. The change in seroprevalence suggests that an HIV-1 epidemic has been developing in recent years in this country, where HIV-2 was originally endemic. A relatively high prevalence of dual-reactive specimens implies the existence of highly cross-reactive strains of HIV or frequent coinfection with HIV-1 and HIV-2 in the region. The large number of seronegative patients with clinically diagnosed AIDS raises the question of the inadequacy of AIDS definitions based on clinical manifestations only.
确定加纳疑似艾滋病患者中与临床表现相关的血清流行率。
1990年和1992年从290名加纳疑似艾滋病患者中采集血样和病历。采用颗粒凝集法、间接免疫荧光法、单表位酶联免疫吸附试验和蛋白质印迹法检测HIV-1、HIV-2和人类T细胞白血病病毒(HTLV-1)的血清流行率。
标本分为五类血清学类别:78例HIV-1阳性(26.9%),25例HIV-2阳性(8.6%),17例双阳性(5.9%),16例不确定(5.5%),154例血清阴性(53.1%)。HIV-1和HIV-2感染患者的临床症状之间未发现显著差异。患者中14例(4.8%)HTLV-1血清阳性,其中11例也为HIV阳性,表明两组病毒感染之间存在显著相关性(P<0.01)。然而,没有证据表明HTLV-1和HIV双重感染病例的症状严重程度增加。
与我们1986年的先前调查显示HIV-2占主导地位相比,目前HIV-1感染在加纳占主导地位。血清流行率的变化表明,近年来在这个原本HIV-2流行的国家,HIV-1疫情一直在发展。双反应性标本的相对高流行率意味着该地区存在高度交叉反应性的HIV毒株或HIV-1和HIV-2的频繁合并感染。大量临床诊断为艾滋病的血清阴性患者引发了仅基于临床表现的艾滋病定义是否充分的问题。